Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 529-20-4 | MDL No. : | MFCD00003338 |
Formula : | C8H8O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BTFQKIATRPGRBS-UHFFFAOYSA-N |
M.W : | 120.15 g/mol | Pubchem ID : | 10722 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 36.8 |
TPSA : | 17.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.43 cm/s |
Log Po/w (iLOGP) : | 1.63 |
Log Po/w (XLOGP3) : | 2.26 |
Log Po/w (WLOGP) : | 1.81 |
Log Po/w (MLOGP) : | 1.78 |
Log Po/w (SILICOS-IT) : | 2.47 |
Consensus Log Po/w : | 1.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.44 |
Solubility : | 0.44 mg/ml ; 0.00366 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.25 |
Solubility : | 0.668 mg/ml ; 0.00556 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.68 |
Solubility : | 0.249 mg/ml ; 0.00207 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21% | With aluminum (III) chloride; bromine In dichloromethane at 0 - 20℃; for 20.33 h; | Intermediate 6: 5-Bromo-2-methylbenzaldehydeTo a solution of 15.1 g (113 mmol) AICI3 in 30 ml_ CH2CI2 at O0C was added dropwise over 20 min 7.50 ml_ (64.8 mmol) of 2-methylbenzaldehyde followed by the dropwise addition of 3.35 ml_ (64.8 mmol) Br2 in 30 ml_ CH2CI2 <n="54"/>over 8 hrs at O0C. The solution was allowed to warm to room temperature over 12 hours then was poured over 50Og ice. This mixture was extracted with 400 ml_ CH2CI2 and the organics washed with 250 ml_ 1.0 N HCI (aq), 250 ml_ sat. NaHCO3 (aq) and 250 ml_ brine then dried over Na2SO4. The solution was concentrated then the resulting solid was recrystallized twice from 50 ml_ hexanes to give 2.92 g (21 percent) of 5-bromo-2-methylbenzaldehyde as an off-white solid: 1 H NMR (400 MHz, CDCI3). δ 10.21 (s, 1 H), 7.94 (s, 1 H), 7.57 (d, 1 H, J = 8.5 Hz), 7.16 (d, 1 H, J = 8.5 Hz), 2.64 (s, 3H.) |
5% | With aluminum (III) chloride; bromine In dichloromethane at 0 - 20℃; for 18.5 h; | Example 15E 5-Bromo-2-methylbenzaldehyde 77.7 g (583 mmol) of aluminium trichloride are suspended in 200 ml of dichloromethane and cooled to 0° C. 40.0 g (333 mmol) of 2-methylbenzaldehyde are added dropwise over the course of 30 min. Then 53.2 g (333 mmol) of bromine are added at 0° C. over the course of 6 h, and the mixture is allowed to warm to RT and is stirred for 12 h. The reaction solution is added to 500 ml of ice-water. The aqueous phase is extracted several times with dichloromethane. The combined organic phases are washed successively with 2N hydrochloric acid, a saturated aqueous sodium bicarbonate solution and a saturated aqueous sodium chloride solution. The organic phase is dried over sodium sulfate and concentrated in vacuo. Purification is by silica gel chromatography and subsequently by crystallization from cyclohexane. The precipitated product is filtered off. Yield: 3.2 g (5percent of theory) LC-MS (method 9): Rt=3.26 min MS (EI): m/z=199 (M+H)+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93.2% | Stage #1: at 25℃; for 0.5 h; Stage #2: With sodium tetrahydroborate In methanol; water at 0 - 25℃; for 1 h; |
To a solution of 2-methylbenzaldehyde (10.0 g, 83.23 mmol) in MeOH at 25° C. was added methylamine (40 percent in H2O, 25.85 g, 332.9 mmol). The reaction mixture was stirred at 25° C. for 30 min after which time it was cooled to 0° C. and NaBH4 (6.30 g, 166.5 mmol) was added portion-wise. The reaction mixture was then warmed to 25° C. and stirred for an additional 1 hr. The solvent was removed under reduced pressure and water and CH2Cl2 were added. The organic layer was separated and washed with saturated NaHCO3 and brine. After drying over Na2SO4, organic phase was concentrated to afford desired methyl-(2-methyl-benzyl)-amine (10.49 g, 93.2percent) as an oil of sufficient purity for use in the next reaction: MS(APCI+) 136.3 m/z (M+H); H-NMR (CDCl3) δ 7.35-7.08 (m, 3 H), 3.73 (s, 2 H), 2.49 (s, 3 H), 2.34 (s, 3 H). |